The treatment, now available in England, targets myeloma, a blood cancer affecting plasma cells in the bone marrow. It ...

This valuable manuscript investigates the localisation of nutrient receptors in bloodstream stage trypanosomes, with implications for both nutrient uptake and immune evasion. Results after direct ...

Multiple myeloma (MM) is a form of blood cancer that originates from plasma cells – part of the white blood cell produced by ...

EXCLUSIVE: A top doctor has shared five common symptoms which could be a sign that something is seriously wrong.

A new antibody treatment prevents cholesterol buildup in heart mitochondria and restores energy production, offering hope for ...

Government data projects nearly 620,000 cancer deaths in the U.S. this year. However, a new "Trojan horse" therapy could ...

Jacob E. Berchuck, MD, discusses research on plasma epigenomic profiling in metastatic castration-resistant prostate cancer.

ABy bding BLyS, BENLYSTA inhibits the prolonged survival of B cells, including autoreactive B cells, and reduces the differentiation of B cells into immunoglobulin-producing plasma cells ... fully ...

Around 1,500 people with multiple myeloma will benefit from belantamab mafodotin, used in combination with bortezomib and ...

This article explores the complex roles of cytokine networks in the development and progression of autoimmune diseases.

DataM Intelligence | competitive Intelligence Explore the evolving Multiple Myeloma market: drug innovations, emerging therapies, and key p ...

Severe autoimmune-mediated neuropathies, such as chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) and ...